CA993389A - Procede d'obtention d'.alpha. et .beta. glycoproteines lentes - Google Patents

Procede d'obtention d'.alpha. et .beta. glycoproteines lentes

Info

Publication number
CA993389A
CA993389A CA163,703A CA163703A CA993389A CA 993389 A CA993389 A CA 993389A CA 163703 A CA163703 A CA 163703A CA 993389 A CA993389 A CA 993389A
Authority
CA
Canada
Prior art keywords
glycoproteins
beta
alpha
achieving
slow
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired
Application number
CA163,703A
Other languages
English (en)
French (fr)
Other versions
CA163703S (en
Inventor
Jean-Pierre Buret
Jean Hirsch
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Sanofi Aventis France
Original Assignee
Roussel Uclaf SA
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Roussel Uclaf SA filed Critical Roussel Uclaf SA
Application granted granted Critical
Publication of CA993389A publication Critical patent/CA993389A/fr
Expired legal-status Critical Current

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/195—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from bacteria
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P37/00—Drugs for immunological or allergic disorders
    • A61P37/02—Immunomodulators
    • A61P37/04—Immunostimulants
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/195—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from bacteria
    • C07K14/24—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from bacteria from Enterobacteriaceae (F), e.g. Citrobacter, Serratia, Proteus, Providencia, Morganella, Yersinia
    • C07K14/26—Klebsiella (G)
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Medicinal Chemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Immunology (AREA)
  • Public Health (AREA)
  • Molecular Biology (AREA)
  • General Chemical & Material Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Animal Behavior & Ethology (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Veterinary Medicine (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Biochemistry (AREA)
  • Biophysics (AREA)
  • Genetics & Genomics (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Engineering & Computer Science (AREA)
  • Pain & Pain Management (AREA)
  • Rheumatology (AREA)
  • Peptides Or Proteins (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Preparation Of Compounds By Using Micro-Organisms (AREA)
  • Medicines Containing Material From Animals Or Micro-Organisms (AREA)
  • Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
CA163,703A 1972-02-15 1973-02-14 Procede d'obtention d'.alpha. et .beta. glycoproteines lentes Expired CA993389A (fr)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
FR7205016A FR2171907B2 (US06312121-20011106-C00033.png) 1972-02-15 1972-02-15

Publications (1)

Publication Number Publication Date
CA993389A true CA993389A (fr) 1976-07-20

Family

ID=9093508

Family Applications (1)

Application Number Title Priority Date Filing Date
CA163,703A Expired CA993389A (fr) 1972-02-15 1973-02-14 Procede d'obtention d'.alpha. et .beta. glycoproteines lentes

Country Status (12)

Country Link
JP (2) JPS4896792A (US06312121-20011106-C00033.png)
BE (1) BE795417A (US06312121-20011106-C00033.png)
CA (1) CA993389A (US06312121-20011106-C00033.png)
CH (1) CH564084A5 (US06312121-20011106-C00033.png)
DE (1) DE2307051C3 (US06312121-20011106-C00033.png)
DK (1) DK146724C (US06312121-20011106-C00033.png)
ES (1) ES411602A2 (US06312121-20011106-C00033.png)
FR (1) FR2171907B2 (US06312121-20011106-C00033.png)
GB (1) GB1412202A (US06312121-20011106-C00033.png)
HU (1) HU168849B (US06312121-20011106-C00033.png)
NL (1) NL174267C (US06312121-20011106-C00033.png)
SE (1) SE425833B (US06312121-20011106-C00033.png)

Families Citing this family (9)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CH633188A5 (fr) * 1978-05-26 1982-11-30 Om Laboratoires Sa Medicament contre des maladies infectieuses des voies respiratoires.
FR2462477A1 (fr) * 1979-07-31 1981-02-13 Cassenne Lab Sa Nouvelles glycoproteines de klebsiella pneumoniae, procede d'obtention, application a titre de medicaments et compositions les renfermant
FR2490496A1 (fr) * 1980-09-19 1982-03-26 Roussel Uclaf Nouvelles glycoproteines immunostimulantes extraites de klebsiella pneumoniae, leur procede d'obtention, leur application a titre de medicaments et les compositions les renfermant
FR2490495A1 (fr) * 1980-09-19 1982-03-26 Roussel Uclaf Nouvelles glycoproteines hydrosolubles immunostimulantes extraites de klebsiella pneumoniae, leur procede d'obtention, leur application a titre de medicaments et les compositions les renfermant
FR2523154A1 (fr) * 1982-03-09 1983-09-16 Fabre Sa Pierre Procede de preparation de proteoglycanes immunostimulants inducteurs d'interferon, proteoglycanes obtenus et medicaments les contenant
FR2574429B1 (fr) * 1984-12-06 1987-12-11 Roussel Uclaf Acylglycannes extraits de klebsiella, leur procede d'obtention, leur application a titre de medicaments et les compositions les renfermant
IT1199301B (it) * 1986-11-21 1988-12-30 Belfanti Ist Sieroterap Milan Lisato antigenico batterico,procedimento per la sua preparazione e composizioni farmaceutiche che lo contengono
FR2653014B1 (fr) * 1989-10-17 1994-09-16 Roussel Uclaf Utilisation de glycoproteines extraites de bacteries gram (-) pour la fabrication de compositions cosmetiques ou dermatologiques et compositions les renfermant.
CH699786A2 (fr) * 2008-10-31 2010-05-14 Marie-Christine Dr Etienne Médicament déstiné à traiter des infections.

Also Published As

Publication number Publication date
JPS59219236A (ja) 1984-12-10
JPS4896792A (US06312121-20011106-C00033.png) 1973-12-10
NL7302132A (US06312121-20011106-C00033.png) 1973-08-17
DE2307051A1 (de) 1973-08-23
ES411602A2 (es) 1976-03-01
DK146724C (da) 1984-05-28
SE425833B (sv) 1982-11-15
JPS6028813B2 (ja) 1985-07-06
CH564084A5 (US06312121-20011106-C00033.png) 1975-07-15
NL174267C (nl) 1984-05-16
DE2307051B2 (de) 1979-10-04
FR2171907A2 (US06312121-20011106-C00033.png) 1973-09-28
BE795417A (fr) 1973-08-14
GB1412202A (en) 1975-10-29
FR2171907B2 (US06312121-20011106-C00033.png) 1975-04-25
DK146724B (da) 1983-12-12
HU168849B (US06312121-20011106-C00033.png) 1976-07-28
DE2307051C3 (de) 1980-06-19

Similar Documents

Publication Publication Date Title
CA937028A (en) Pseudoboehmitic alumina and process for making same
CA1008849A (en) Ap-glycoproteins and process for isolating them
CA993389A (fr) Procede d'obtention d'.alpha. et .beta. glycoproteines lentes
CA930728A (en) 3-amino-cardenolides and process for their manufacture
CA949962A (en) 3.beta.-HYDROXY-5.alpha.-CARDENOLIDES AND -BUFADIENOLIDES AND PROCESS FOR THEIR MANUFACTURE
CA956317A (en) Pyridyl-methoxyamines and process for preparing same
CA944355A (en) N-vinyl-quinolones and process for their preparation
AU2402571A (en) Pteridine-glycosides and process for their manufacture
CA949554A (en) 3-n-alkyl-amino-cardenolides and process for their manufacture
CA945089A (en) Antibiotic complex s-3466 and process for making same
CA857894A (en) DERIVATIVES OF .alpha.-PIPERAZINOPHENYL-ACETONITRILE AND PROCESS FOR MANUFACTURE OF SAME
AU2877371A (en) New carbanyloxyquinolne and process for its preparation
CA857880A (en) Cycloheptadienes and process for preparing same
CA835393A (en) 4-hydroxy-quinolines and process for preparing same
CA853694A (en) 17.beta.-LACTONES OF 14.beta.-HYDROXY-STEROIDS AND PROCESS FOR PREPARING THEM
AU442178B2 (en) O acyl lysergols and process for preparing them
CA832007A (en) Benzenesulfonyl-ureas and process for preparing them
CA849569A (en) Benzenesulfonyl-ureas and process for preparing them
CA849547A (en) Benzenesulfonyl-ureas and process for preparing them
CA849523A (en) 3-aminoacylamino-thiophens and process for preparing them
CA848450A (en) Benzenesulfonyl-ureas and process for preparing them
CA845714A (en) Benzenesulfonyl-ureas and process for preparing them
CA833568A (en) Benzenesulfonyl-ureas and process for preparing them
CA853704A (en) Benzenesulfonyl-ureas and process for preparing them
CA840444A (en) 1-aminoalkyl-1-phenylindene process and intermediate therefor